Hippo tumor supressor pathway: Novel implications for the treatment of hepatocellular carcinoma

Gastroenterology

Volumn 139, Issue 2, 2010, Pages 692-694

  Lachenmayer, Anja ^a,b   Hoshida, Yujin ^c,d   Llovet, Josep M ^a,e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; RAS PROTEIN; SCATTER FACTOR RECEPTOR; SOMATOMEDIN; TRANSCRIPTION FACTOR YAP1; TUMOR SUPPRESSOR PROTEIN; WNT PROTEIN;

ADVANCED CANCER; APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; GENE DELETION; GENE EXPRESSION; HUMAN; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; NOTE; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77955481151     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.06.036     Document Type: Note

References (0)